uniQure Future Growth
Future criteria checks 2/6
uniQure is forecast to grow earnings and revenue by 34.4% and 42.8% per annum respectively. EPS is expected to grow by 36.1% per annum. Return on equity is forecast to be -38.2% in 3 years.
Key information
34.4%
Earnings growth rate
36.1%
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | 42.8% |
Future return on equity | -38.2% |
Analyst coverage | Good |
Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 175 | -127 | -63 | -83 | 13 |
12/31/2023 | 188 | -84 | 2 | -20 | 15 |
12/31/2022 | 26 | -176 | -139 | -106 | 16 |
9/30/2022 | 61 | -125 | N/A | N/A | N/A |
6/30/2022 | 62 | -114 | -149 | -129 | N/A |
3/31/2022 | 525 | 324 | 286 | 304 | N/A |
12/31/2021 | 524 | 330 | 271 | 288 | N/A |
9/30/2021 | 500 | 321 | 281 | 298 | N/A |
6/30/2021 | 500 | 303 | 292 | 303 | N/A |
3/31/2021 | 38 | -139 | -154 | -143 | N/A |
12/31/2020 | 38 | -125 | -144 | -135 | N/A |
9/30/2020 | 6 | -166 | -132 | -124 | N/A |
6/30/2020 | 5 | -136 | -120 | -111 | N/A |
3/31/2020 | 6 | -124 | -114 | -105 | N/A |
12/31/2019 | 7 | -124 | -105 | -99 | N/A |
9/30/2019 | 6 | -105 | -96 | -91 | N/A |
6/30/2019 | 8 | -103 | -93 | -89 | N/A |
3/31/2019 | 9 | -92 | -86 | -81 | N/A |
12/31/2018 | 11 | -83 | -80 | -76 | N/A |
9/30/2018 | 12 | -90 | -81 | -76 | N/A |
6/30/2018 | 11 | -78 | -76 | -71 | N/A |
3/31/2018 | 13 | -78 | -78 | -74 | N/A |
12/31/2017 | 13 | -79 | -70 | -64 | N/A |
9/30/2017 | 20 | -67 | -71 | -62 | N/A |
6/30/2017 | 25 | -72 | -82 | -65 | N/A |
3/31/2017 | 24 | -71 | -85 | -68 | N/A |
12/31/2016 | 25 | -73 | -89 | -72 | N/A |
9/30/2016 | 20 | -76 | -95 | -81 | N/A |
6/30/2016 | 16 | -90 | N/A | -62 | N/A |
3/31/2016 | 14 | -90 | N/A | 5 | N/A |
12/31/2015 | 11 | -82 | N/A | 7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: UQ1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: UQ1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: UQ1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: UQ1's revenue (42.8% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: UQ1's revenue (42.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: UQ1 is forecast to be unprofitable in 3 years.